Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis.
OBJECTIVE
To perform a systematic literature review (SLR) on pharmacological and non-pharmacological treatments, in order to inform the European League Against Rheumatism (EULAR) recommendations for the management of early arthritis (EA).


METHODS
The expert committee defined research questions concerning non-pharmacological interventions, patient information and education, non-steroidal anti-inflammatory drug, glucocorticoid (GC) and disease-modifying antirheumatic drugs (DMARDs) use, as well as on disease monitoring. The SLR included articles published after the last EULAR SLR until November 2015 found in the MEDLINE, EMBASE and Cochrane databases and abstracts from the 2014 and 2015 American College of Rheumatology and EULAR conferences.


RESULTS
Exercise programmes may improve pain and physical function in patients with EA. Patients with EA treated within the first 3 months of symptoms have better clinical and radiological outcomes than those treated beyond 3 months. The clinical and radiological efficacy of GCs is confirmed, with similar efficacy of oral and parenteral administrations. Long-term data raise concerns regarding cardiovascular safety when using GCs. Step-up DMARD therapy is as effective as intensive DMARD therapy 'ab initio' for the long-term outcome of EA. Short-term superiority of intensive therapy with bDMARDs is not maintained on withdrawal of bDMARD. Patients with early psoriatic arthritis have better skin and joint outcomes when tight control is used compared to standard care.


CONCLUSIONS
The findings confirm the beneficial effect of exercise programmes and the importance of early drug therapy and tight control. They support the use of methotrexate and GCs as first-line drugs, although the long-term use of GCs raises safety concerns.
Rheumatology department , Lapeyronie Hospital, Montpellier University , Montpellier , France.
Claire Immediato
CI
Daien
Rheumatology department , Lapeyronie Hospital, Montpellier University , Montpellier , France.
Charlotte
C
Hua
Rheumatology department , Lapeyronie Hospital, Montpellier University , Montpellier , France.
Bernard
B
Combe
Department of Clinical Immunology & Rheumatology , Amsterdam Rheumatology Center, Amsterdam & Zuyderland Medical Centre , Heerlen , The Netherlands.
Robert
R
Landewe
Corticosteroids; DMARDs (biologic); DMARDs (synthetic); Early Rheumatoid Arthritis; Physcial therapy